Dokmetas M, Muglu H, Ozcan E, Bayram Kuvvet B, Helvaci K, Kalaci E
Medicina (Kaunas). 2025; 61(1).
PMID: 39859105
PMC: 11766766.
DOI: 10.3390/medicina61010123.
Mason N, Chester N, Xiong A, Rotolo A, Wu Y, Yoshimoto S
MAbs. 2021; 13(1):2004638.
PMID: 34856888
PMC: 8726733.
DOI: 10.1080/19420862.2021.2004638.
Hoffner B, Vaughn R, Reed M, Weber M
J Adv Pract Oncol. 2020; 10(4):367-386.
PMID: 33343985
PMC: 7520742.
DOI: 10.6004/jadpro.2019.10.4.5.
Sadeghi Rad H, Monkman J, Warkiani M, Ladwa R, OByrne K, Rezaei N
Med Res Rev. 2020; 41(3):1474-1498.
PMID: 33277742
PMC: 8247330.
DOI: 10.1002/med.21765.
Galanzha E, Menyaev Y, Yadem A, Sarimollaoglu M, Juratli M, Nedosekin D
Sci Transl Med. 2019; 11(496).
PMID: 31189720
PMC: 9235419.
DOI: 10.1126/scitranslmed.aat5857.
Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.
Yoest J
Immunotargets Ther. 2017; 6:73-82.
PMID: 29067284
PMC: 5644546.
DOI: 10.2147/ITT.S126227.
Immunological characterization of a rigid α-Tn mimetic on murine iNKT and human NK cells.
Fallarini S, Brittoli A, Fiore M, Lombardi G, Renaudet O, Richichi B
Glycoconj J. 2017; 34(4):553-562.
PMID: 28573337
DOI: 10.1007/s10719-017-9775-6.
Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.
Anderson K, Modiano J
Vet Sci. 2016; 2(4):363-387.
PMID: 27066495
PMC: 4826068.
DOI: 10.3390/vetsci2040363.
Trial Watch: Peptide-based anticancer vaccines.
Pol J, Bloy N, Buque A, Eggermont A, Cremer I, Sautes-Fridman C
Oncoimmunology. 2015; 4(4):e974411.
PMID: 26137405
PMC: 4485775.
DOI: 10.4161/2162402X.2014.974411.
Trial watch: Immunostimulatory cytokines in cancer therapy.
Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I
Oncoimmunology. 2014; 3:e29030.
PMID: 25083328
PMC: 4091551.
DOI: 10.4161/onci.29030.
